Basics Tenaya Therapeutics, Inc. IPO Date: June 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $73.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 4.65% Avg Daily Range (30 D): $0.02 | 4.43% Avg Daily Range (90 D): $0.04 | 5.10% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): 1.88M Avg Daily Volume (90 D): 2.67M Trade Size Avg Trade Size (Sh.): 215 Avg Trade Size (Sh.) (30 D): 426 Avg Trade Size (Sh.) (90 D): 505 Institutional Trades Total Inst.Trades: 103 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.26M Avg Closing Trade (30 D): $.9M Avg Closing Trade (90 D): $.9M Avg Closing Volume: 420.05K         News Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc. Jun 18, 2024 @ 8:30 PM Tenaya Therapeutics to Participate at the TD Cowen... Source: Tenaya Therapeutics, Inc. May 14, 2024 @ 8:05 PM Tenaya Therapeutics Reports First Quarter 2024 Fin... Source: Tenaya Therapeutics, Inc. May 2, 2024 @ 9:00 PM Tenaya Therapeutics to Highlight Growing Capabilit... Source: Tenaya Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.15 $-.24 $-.27 Diluted EPS $-1.15 $-.24 $-.27 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -105.77M $ -26.86M $ -23.84M Operating Income / Loss $ -109.72M $ -27.54M $ -24.65M Cost of Revenue $ $ $ Net Cash Flow $ -5.79M $ 49.45M $ -3.91M PE Ratio